Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase

Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT) with Enhanced Activity Mechanisms and inhibitors of nicotinamide N-methyltransferase Structure–Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Potent Uncompetitive Inhibitors of Nicotinamide N-Methyltransferase (NNMT) as In Vivo Chemical Probes Novel Propargyl-Linked Bisubstrate Analogues as Tight-Binding Inhibitors for Nicotinamide N-Methyltransferase Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group Comparative molecular field analysis (CoMFA) models of phenylethanolamine N-methyltransferase (PNMT) and the α2-adrenoceptor: The development of new, highly selective inhibitors of PNMT Nicotinamide N-Oxidation by CYP2E1 in Human Liver Microsomes Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine N-Methyltransferase Possessing Low Nanomolar Affinity at Both Substrate Binding Domains¹